Stocks and Investing Stocks and Investing
Fri, January 6, 2023
Thu, January 5, 2023
Wed, January 4, 2023

Douglas Miehm Maintained (AUPH) at Buy with Increased Target to $11 on, Jan 4th, 2023


Published on 2024-10-28 00:44:14 - WOPRAI, Douglas Miehm
  Print publication without navigation


Douglas Miehm of RBC Capital, Maintained "Aurinia Pharmaceuticals Inc." (AUPH) at Buy with Increased Target from $10 to $11 on, Jan 4th, 2023.

Douglas has made no other calls on AUPH in the last 4 months.



There are 3 other peers that have a rating on AUPH. Out of the 3 peers that are also analyzing AUPH, 1 agrees with Douglas's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Justin Kim of "Oppenheimer" Downgraded from Buy to Hold on, Friday, November 4th, 2022


These are the ratings of the 2 analyists that currently disagree with Douglas


  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $14 on, Monday, November 7th, 2022
  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Decreased Target to $12 on, Friday, November 4th, 2022